Mark H Hubbard, CAB Member
Vanderbilt CRS, Nashville, TN, USA
Mark Hubbard has lived with HIV/AIDS for over 30 years and has served on Vanderbilt community advisory boards since 2001. He is currently an alternate global community advisory board representative for Vanderbilt for both the HVTN and the ACTG networks.
Mark works with local and regional groups as well as international organizations, including the AIDS Treatment Advocacy Coalition Drug Development Committee, the biomedical HIV prevention research advocacy agency AVAC, and the International Rectal Microbicides Advocates.
Mark has participated in community consultations with the Tennessee Department of Health, the US Centers for Disease Control (CDC), the NIH's National Institute of Allergies and Infectious Disease (NIAID), and the Microbicides Trials Network. He currently serves on the State of Tennessee Department of Health’s HIV Center of Excellence (Ryan White Clinic Oversight), and the AIDS Drug Assistance Program (ADAP) formulary and medical fee schedule committees.
Mark was awarded 6 consecutive community educator scholarships to the Conference on Retroviruses and Opportunistic Infections and is serving in his third year on the CROI Planning Committee Community Liaison Subcommittee.
Mark is a community representative to the HIV Vaccine Trial Network’s Efficacy Trials Working Group and its Scientific Governance Committee. He is a member of the HVTN/HPTN AMP protocol teams (HVTN 704/HPTN 085 and HVTN 703/HPTN 081). In May of 2016, the HVTN honored him with the Octavio Valente Junior Volunteer Service Award.
One thing he loves about working with the HVTN is the commitment to excellence in every aspect of what the HVTN does – from start to finish, from top to bottom, and across disciplines.